Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8470)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 14, 2022 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yasmin F, Najeeb H, Shaikh S, Hasanain M, Naeem U, Moeed A, Koritala T, Hasan S, Surani S. Novel drug delivery systems for inflammatory bowel disease. World J Gastroenterol 2022; 28(18): 1922-1933 [PMID: 35664964 DOI: 10.3748/wjg.v28.i18.1922] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i18/1922.htm |
| Number | Citing Articles |
| 1 |
You Chen, Juewen Feng, Yang Chen, Chuanhe Xia, Min Yao, Wenxing Ding, Xiang Li, Xiuzhi Fu, Shulei Zheng, Yin Ma, Jiafeng Zou, Minbo Lan, Feng Gao. ROS-responsive nano-medicine for navigating autophagy to enhance targeted therapy of inflammatory bowel disease. International Journal of Pharmaceutics 2024; : 124117 doi: 10.1016/j.ijpharm.2024.124117
|
| 2 |
Salvatore Rizzo, Elide Zingale, Alessia Romeo, Rosamaria Lombardo, Rosario Pignatello. Colon Delivery of Nutraceutical Ingredients by Food-Grade Polymeric Systems: An Overview of Technological Characterization and Biological Evaluation. Applied Sciences 2023; 13(9): 5443 doi: 10.3390/app13095443
|
| 3 |
Enhui Tang, Tong Hu, Zhaokang Jiang, Xiaojun Shen, Huan Lin, Haiyan Xian, Xinlan Wu. Isoquercitrin alleviates lipopolysaccharide-induced intestinal mucosal barrier damage in mice by regulating TLR4/MyD88/NF-κB signaling pathway and intestinal flora. Food & Function 2024; 15(1): 295 doi: 10.1039/D3FO03319H
|
| 4 |
Shaymaa S. Seoudi, Eman A. Allam, Amal H. El-Kamel, Hagar Elkafrawy, Riham M. El-Moslemany. Targeted delivery of budesonide in acetic acid induced colitis: impact on miR-21 and E-cadherin expression. Drug Delivery and Translational Research 2023; 13(11): 2930 doi: 10.1007/s13346-023-01363-2
|
| 5 |
Jagtar Singh, Mohit Sharma, Harmeet Singh, Pinky Arora, Puneet Utreja, Shubham Kumar. Formulation, Characterization and In Vitro Evaluation of Mesalamine and Bifidobacterium bifidum Loaded Hydrogel Beads in Capsule System for Colon Targeted Delivery. AAPS PharmSciTech 2024; 25(3) doi: 10.1208/s12249-024-02764-3
|
| 6 |
Seyed Yaser Vafaei, Amir Hossein Abdolghaffari, Reza Mahjub, Seyyed Majid Eslami, Motahareh Esmaeili, Mohammad Abdollahi, Fatemeh Atyabi, Rassoul Dinarvand, Abdul Ahad. Budesonide-Loaded Hyaluronic Acid Nanoparticles for Targeted Delivery to the Inflamed Intestinal Mucosa in a Rodent Model of Colitis. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/7776092
|
| 7 |
Yinfeng Zhang, Tingting Wang, Meng Sun, Yueyue Song, Xinyuan Huang, Shutian Zhang, Jun Yang, Jinfeng Zhang. Advanced Nanomedicine: Redefining Therapeutic Paradigms for Inflammatory Bowel Disease. Advanced Healthcare Materials 2023; 12(19) doi: 10.1002/adhm.202300069
|
| 8 |
Dinakar Swastha, Nambolan Varsha, Suresh Aravind, Kavassery Balasubramanian Samyuktha, Muruganandam Mohaneswari Yokesh, Akshad Balde, Bakthavatchalam Loganathan Ayilya, Soottawat Benjakul, Se-Kwon Kim, Rasool Abdul Nazeer. Alginate-based drug carrier systems to target inflammatory bowel disease: A review. International Journal of Biological Macromolecules 2023; 244: 125472 doi: 10.1016/j.ijbiomac.2023.125472
|
| 9 |
Bo Wang, Jiquan Shen, Xinggao Wang, Ruixing Hou. Biomimetic nanoparticles for effective Celastrol delivery to targeted treatment of rheumatoid arthritis through the ROS-NF-κB inflammasome axis. International Immunopharmacology 2024; 131: 111822 doi: 10.1016/j.intimp.2024.111822
|
| 10 |
Sem Geertsema, Arno R. Bourgonje, Raphael R. Fagundes, Ranko Gacesa, Rinse K. Weersma, Harry van Goor, Giovanni E. Mann, Gerard Dijkstra, Klaas N. Faber. The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease. Trends in Molecular Medicine 2023; 29(10): 830 doi: 10.1016/j.molmed.2023.07.008
|
| 11 |
Haisheng Peng, Jiahe Wang, Jiayu Chen, Yanbo Peng, Xiaoxian Wang, Ying Chen, David L. Kaplan, Qun Wang. Challenges and opportunities in delivering oral peptides and proteins. Expert Opinion on Drug Delivery 2023; 20(10): 1349 doi: 10.1080/17425247.2023.2237408
|
| 12 |
Hee-Jun Kim, Bohye Kim, Mi-Ra Lee, Moonjin Ra, Yongjun Lee. Bamboo Shoot and Artemisia capillaris Extract Mixture Ameliorates Dextran Sodium Sulfate-Induced Colitis. Current Issues in Molecular Biology 2022; 44(10): 5086 doi: 10.3390/cimb44100345
|
| 13 |
Katharina Tatjana Kopp, Lien Saerens, Jody Voorspoels, Guy Van den Mooter. Solidification and oral delivery of biologics to the colon- A review. European Journal of Pharmaceutical Sciences 2023; 190: 106523 doi: 10.1016/j.ejps.2023.106523
|
| 14 |
Fatemeh Soltani, Hossein Kamali, Abbas Akhgari, Mahboobeh Ghasemzadeh Rahbardar, Hadi Afrasiabi Garekani, Ali Nokhodchi, Fatemeh Sadeghi. Combination of time-dependent polymer and inulin as a coating for sustained delivery of budesonide pellets aimed for use in IBD treatment. Journal of Drug Delivery Science and Technology 2023; 88: 104927 doi: 10.1016/j.jddst.2023.104927
|
| 15 |
Ranjit K. Harwansh, Hemant Bhati, Rohitas Deshmukh. Recent Updates on the Therapeutics Benefits, Clinical Trials, and Novel
Delivery Systems of Chlorogenic Acid for the Management of Diseases with a
Special Emphasis on Ulcerative Colitis. Current Pharmaceutical Design 2024; 30(6): 420 doi: 10.2174/0113816128295753240129074035
|
| 16 |
Parisa Hashemi, Shirin Mahmoodi, Abdolmajid Ghasemian. An updated review on oral protein-based antigen vaccines efficiency and delivery approaches: a special attention to infectious diseases. Archives of Microbiology 2023; 205(8) doi: 10.1007/s00203-023-03629-2
|
| 17 |
Chunhua Yang, Kripa Sharma, Rabeya Jafrin Mow, Eunice Bolay, Anand Srinivasan, Didier Merlin. Unleashing the Potential of Oral Deliverable Nanomedicine in the Treatment of Inflammatory Bowel Disease. Cellular and Molecular Gastroenterology and Hepatology 2024; doi: 10.1016/j.jcmgh.2024.03.005
|
| 18 |
Chia Wen Qi, Ummu Umaimah Mohd Nordin, Syed Mahmood, Nisha Rata Karusan, Ramsha Khalid, Nurdiana Nordin, Cristina Fornaguera, Noraini Ahmad. Gout Management Using Nanocarrier Systems: A Review. ACS Applied Nano Materials 2024; doi: 10.1021/acsanm.3c06079
|
| 19 |
Raj Kumar, Tamanna Islam, Md Nurunnabi. Mucoadhesive carriers for oral drug delivery. Journal of Controlled Release 2022; 351: 504 doi: 10.1016/j.jconrel.2022.09.024
|
| 20 |
Dongdong Liu, Meng Wei, Wenrui Yan, Hua Xie, Yingbao Sun, Bochuan Yuan, Yiguang Jin. Potential applications of drug delivery technologies against radiation enteritis. Expert Opinion on Drug Delivery 2023; 20(4): 435 doi: 10.1080/17425247.2023.2183948
|
| 21 |
Chin-Hsiao Tseng. Rosiglitazone Does Not Affect the Risk of Inflammatory Bowel Disease: A Retrospective Cohort Study in Taiwanese Type 2 Diabetes Patients. Pharmaceuticals 2023; 16(5): 679 doi: 10.3390/ph16050679
|
| 22 |
Yijun Wu, Jinfeng Song, Xiaochen Wang, Longxia Li, Jie Chang, Yunfeng Ma. pH and redox dual response nano-suppository for the treatment of ulcerative colitis. Drug Delivery and Translational Research 2024; doi: 10.1007/s13346-023-01499-1
|
| 23 |
Jia Wang, Yuying Shi, Bei Mao, Biheng Zhang, Jie Yang, Zhijian Hu, Weifang Liao. Biomaterials for inflammatory bowel disease: treatment, diagnosis and organoids. Applied Materials Today 2024; 36: 102078 doi: 10.1016/j.apmt.2024.102078
|